Citation Impact

Citing Papers

Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
2000
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
2005 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
2004 StandoutScience
In silico prediction of protein-protein interactions in human macrophages
2014 Standout
Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus
1992
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection
2006
Bacteremia in Malawian Children with Severe Malaria: Prevalence, Etiology, HIV Coinfection, and Outcome
2007
Syndemics and the biosocial conception of health
2017 Standout
Increased Risk for Severe Malaria in HIV-1–infected Adults, Zambia
2009
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
2009 Standout
Genomic Characterisation of Invasive Non-Typhoidal Salmonella enterica Subspecies enterica Serovar Bovismorbificans Isolates from Malawi
2013
Treatment of Active Tuberculosis in HIV‐Coinfected Patients: A Systematic Review and Meta‐Analysis
2010
Research issues involving HIV-associated tuberculosis in resource-poor countries
1996
A Prospective, Randomized Trial Examining the Efficacy and Safety of Clarithromycin in Combination with Ethambutol, Rifabutin, or Both for the Treatment of Disseminated Mycobacterium avium Complex Disease in Persons with Acquired Immunodeficiency Syndrome
2003
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa
2007
Tuberculosis
2011
Normal rat hepatic stellate cells respond to endotoxin in LBP‐independent manner to produce inhibitor(s) of DNA synthesis in hepatocytes
2005
The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease
2007
Pneumocystis carinii Pneumonia: An Uncommon Cause of Death in African Patients with Acquired Immunodeficiency Syndrome
1992
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
2010
Botulinum Toxin as a Biological Weapon
2001 Standout
Brucellosis: an Overview
1997 Standout
The burden of non-communicable diseases in South Africa
2009 Standout
Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal Infections
2014
Melioidosis
2012 Standout
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Development of Vaccines Against Burkholderia Pseudomallei
2011
The Detection of Airborne Transmission of Tuberculosis from HIV-Infected Patients, Using an In Vivo Air Sampling Model
2007
Antimicrobial resistance in developing countries. Part I: recent trends and current status
2005
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
Brucellosis
2005 Standout
Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results
1992
HIV infection in Haiti: natural history and disease progression
2000
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
The HIV-associated tuberculosis epidemic—when will we act?
2010
The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection
2009
Clinical and Laboratory Markers of Hypersensitivity to Trimethoprim-Sulfamethoxazole in Patients with Pneumocystis carinii Pneumonia and AIDS
1993
Global Burden of Tuberculosis
1999 Standout
General considerations for lung function testing
2005 Standout
Malaria
2013 Standout
Tuberculosis in Patients Infected with Human Immunodeficiency Virus: Perspective on the Past Decade
1996
Sources of Disseminated Mycobacterium avium Infection in AIDS
2002
Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS
1994
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
Hospital Water as a Source ofMycobacterium aviumComplex Isolates in Respiratory Specimens
2004
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
2006 Standout
Nontuberculous mycobacteria in the environment
2002
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
1995 Standout
Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals
2020 StandoutNature
HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners
2000
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis
2008
Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment
2006
Clinical recognition and management of patients exposed to biological warfare agents
1997
Tularemia as a Biological Weapon
2001 Standout
Human brucellosis
2007 Standout
CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial
2006
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
2010 Standout
Treatment of Multidrug-Resistant Tuberculosis
1993
The clinical challenge of the HIV epidemic in the developing world
1993
Recognition and Optimum Treatment of Brucellosis
1997
Opportunities and Challenges for HIV Care in Overlapping HIV and TB Epidemics
2008
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes
2007
A marker for Stevens–Johnson syndrome
2004 StandoutNature
Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis
2010 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Maternal mortality: who, when, where, and why
2006 Standout
Tuberculosis and HIV infection in sub-Saharan Africa
1992
Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection
2006
The Growing Burden of Tuberculosis
2003 Standout
Silicosis
2012 Standout
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults
2002
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death.
1999
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
1993 Standout
Sequestration From Immune CD4 + T Cells of Mycobacteria Growing in Human Macrophages
1993 StandoutScienceNobel
The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation.
1996 StandoutNobel
Extensively Drug-Resistant Tuberculosis: A New Face to an Old Pathogen
2009
Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs
2009
Prevention of Laboratory-Acquired Brucellosis
2004
Rv2131c fromMycobacterium tuberculosisIs a CysQ 3′-Phosphoadenosine-5′-phosphatase
2008 StandoutNobel
A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis
2019 StandoutNobel
Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins
2014 Standout
Age-dependent humoral responses of children to mycobacterial antigens
1995
Laboratory-acquired Brucellosis
2004
Impact of Nonlinear Interactions of Pharmacokinetics and MICs on Sputum Bacillary Kill Rates as a Marker of Sterilizing Effect in Tuberculosis
2014
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
2000
Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing Guidelines
2012
Laboratory Exposures to Brucellae and Implications for Bioterrorism
2005
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
Case 27-2000
2000
Epidemiology of infection by nontuberculous mycobacteria
1996
Lipopolysaccharide Endotoxins
2002 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Impact of human immunodeficiency virus infection on the outcome of treatment and survival of tuberculosis patients in Mwanza, Tanzania.
1998
Effects of Human Immunodeficiency Virus Infection on Recurrence of Tuberculosis after Rifampin-Based Treatment: An Analytical Review
2003
Cutaneous Drug Reactions
2001
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Clinical Management ofStaphylococcus aureusBacteremia
2014

Works of Richard Brindle being referenced

Biochemical mis-identification of Brucella melitensis and subsequent laboratory-acquired infections
1992
Penicillin to Prevent Recurrent Leg Cellulitis
2013
Infection and morbidity in patients with tuberculosis in Nairobi, Kenya
1993
Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis
2001
Brucellosis: imported and laboratory-acquired cases, and an overview of treatment trials
1993
Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom
2009
Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya
1993
Role for tumor necrosis factor α receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin
1999
Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis
1991
Recent transmission of tuberculosis in a cohort of HIV-1-infected female sex workers in Nairobi, Kenya
1997
Evidence of Previous Infection with Mycobacterium avium-Mycobacterium intracellulare Complex among Healthy Subjects: An International Study of Dominant Mycobacterial Skin Test Reactions
1993
Quantitative Bacillary Response to Treatment in HIV-associated Pulmonary Tuberculosis
1993
No association between meningococcal disease and human immunodeficiency virus in adults in Nairobi, Kenya
1991
The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis
1994
The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS
1996
Clinical isolates of HIV-associated cryptococcosis in Nairobi, Kenya
1994
Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya
1996
Extrapulmonary and disseminated tuberculosis in HIV-1-seropositive patients presenting to the acute medical services in Nairobi
1990
Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya
1990
Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya
1993
Disseminated Mycobacterium avium Infection Among HIV-Infected Patients in Kenya
1995
Use of Nonlinear Mixed-Effects Analysis for Improved Precision of Early Pharmacodynamic Measures in Tuberculosis Treatment
2006
Rankless by CCL
2026